Sale!

AQP2 Gene Diabetes Insipidus Nephrogenic Autosomal Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AQP2 gene plays a crucial role in the body’s water balance mechanism, specifically in the kidney’s ability to concentrate urine. Mutations in the AQP2 gene can lead to Nephrogenic Diabetes Insipidus (NDI), a condition characterized by the kidney’s inability to respond to the antidiuretic hormone, leading to excessive production of dilute urine, dehydration, and a constant need for water. NDI can be inherited in an autosomal manner, meaning the genetic mutation can be passed down from parents to offspring.

To diagnose this condition, a genetic test focusing on the AQP2 gene can be conducted. This test is crucial for identifying the specific mutation within the AQP2 gene that is causing NDI. Early diagnosis and identification of the genetic mutation are essential for managing symptoms and preventing complications associated with NDI.

In the UAE, this specific genetic test for the AQP2 gene can be performed at DNA Labs UAE. The test cost is set at 4400 AED. DNA Labs UAE offers comprehensive genetic testing services, ensuring accuracy and confidentiality in the diagnosis of Nephrogenic Diabetes Insipidus and other genetic conditions. This test is a vital tool for families with a history of NDI, providing them with the necessary information for managing the condition and making informed health decisions.

Description

AQP2 Gene Diabetes insipidus nephrogenic autosomal Genetic Test

Test Name: AQP2 Gene Diabetes insipidus nephrogenic autosomal Genetic Test

Components: AQP2 gene sequencing

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AQP2 Gene Diabetes insipidus, nephrogenic, autosomal NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AQP2 Gene Diabetes insipidus, nephrogenic, autosomal NGS Genetic DNA Test gene AQP2

Test Details:

The AQP2 gene is responsible for encoding a protein called aquaporin-2, which is involved in the regulation of water balance in the body. Mutations in the AQP2 gene can lead to a condition called nephrogenic diabetes insipidus (NDI). NDI is a rare genetic disorder characterized by the inability of the kidneys to concentrate urine properly, resulting in excessive thirst and production of large amounts of diluted urine. It is called “nephrogenic” because the problem lies in the kidneys’ response to the hormone vasopressin, which normally helps regulate water balance. Autosomal means that the gene mutation is located on one of the autosomes, non-sex chromosomes, and can affect both males and females equally. NDI can be inherited in an autosomal dominant or autosomal recessive manner, depending on the specific genetic mutation involved.

NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that can be used for genetic testing. In the context of NDI, NGS genetic testing involves sequencing the AQP2 gene to identify any mutations or variants that may be causing the condition. NGS genetic testing for AQP2 gene mutations can be useful in diagnosing NDI and determining the specific genetic cause of the condition. It can also be used for carrier testing in families with a history of NDI, as well as for prenatal testing in at-risk pregnancies. Overall, NGS genetic testing for AQP2 gene mutations is a valuable tool in the diagnosis and management of nephrogenic diabetes insipidus.

Test Name	AQP2 Gene Diabetes insipidus nephrogenic autosomal Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hepatology Nephrology Endocrinology Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for AQP2 Gene Diabetes insipidus, nephrogenic, autosomal NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AQP2 Gene Diabetes insipidus, nephrogenic, autosomal NGS Genetic DNA Test gene AQP2
Test Details	The AQP2 gene is responsible for encoding a protein called aquaporin-2, which is involved in the regulation of water balance in the body. Mutations in the AQP2 gene can lead to a condition called nephrogenic diabetes insipidus (NDI). NDI is a rare genetic disorder characterized by the inability of the kidneys to concentrate urine properly, resulting in excessive thirst and production of large amounts of diluted urine. It is called “nephrogenic” because the problem lies in the kidneys’ response to the hormone vasopressin, which normally helps regulate water balance. Autosomal means that the gene mutation is located on one of the autosomes, non-sex chromosomes, and can affect both males and females equally. NDI can be inherited in an autosomal dominant or autosomal recessive manner, depending on the specific genetic mutation involved. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that can be used for genetic testing. In the context of NDI, NGS genetic testing involves sequencing the AQP2 gene to identify any mutations or variants that may be causing the condition. NGS genetic testing for AQP2 gene mutations can be useful in diagnosing NDI and determining the specific genetic cause of the condition. It can also be used for carrier testing in families with a history of NDI, as well as for prenatal testing in at-risk pregnancies. Overall, NGS genetic testing for AQP2 gene mutations is a valuable tool in the diagnosis and management of nephrogenic diabetes insipidus.